4204:TSESekisui Chemical Co., Ltd. Analysis
Data as of 2026-06-21 - not real-time
¥2,471.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Sekisui Chemical (4204.T) is trading at ¥2,471, notably above its DCF‑derived fair value of roughly ¥1,830, suggesting the market is pricing in a premium. The stock’s PE ratio of 13.5 is well below the industry average of 31.4, while the dividend yield of 3.32% and a payout ratio under 45% underscore attractive income potential. Technically, the price sits above the 20‑day SMA (¥2,367) and 50‑day SMA (¥2,424) but remains under the 200‑day SMA (¥2,671), indicating short‑term momentum amid a longer‑term bearish bias. The RSI at 60.8 and a bullish MACD histogram (+22.8) provide some upside momentum, yet decreasing volume and a bearish trend direction flag caution.
Fundamentally, revenue growth is modest at 2% and margins are moderate (gross 32%, operating 9.6%). Strong cash generation (operating cash flow ¥78.3 bn) supports the dividend, though free cash flow is negative. The company’s low beta (0.26) points to limited market volatility, but a 30‑day volatility of 21.7% and a max drawdown near 26% highlight price swings. Diversified exposure across chemicals, plastics, medical and renewable‑energy segments mitigates sector‑specific risks, while the “Extreme Greed” sentiment index (91.46) suggests heightened market optimism.
Fundamentally, revenue growth is modest at 2% and margins are moderate (gross 32%, operating 9.6%). Strong cash generation (operating cash flow ¥78.3 bn) supports the dividend, though free cash flow is negative. The company’s low beta (0.26) points to limited market volatility, but a 30‑day volatility of 21.7% and a max drawdown near 26% highlight price swings. Diversified exposure across chemicals, plastics, medical and renewable‑energy segments mitigates sector‑specific risks, while the “Extreme Greed” sentiment index (91.46) suggests heightened market optimism.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish longer‑term trend (price below 200‑day SMA)
- Decreasing volume and high recent volatility
- Bullish MACD histogram offering limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Attractive dividend yield with sustainable payout
- Valuation premium relative to DCF fair value
- Modest revenue growth and stable operating margins
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Diversified product portfolio across chemicals, medical and renewable sectors
- Low beta indicating defensive characteristics
- Potential upside from perovskite solar and infrastructure renovation businesses
Key Metrics & Analysis
Financial Health
Revenue Growth2.00%
Profit Margin5.74%
P/E Ratio13.5
ROE9.01%
ROA4.82%
Debt/Equity16.43
P/B Ratio1.2
Op. Cash Flow¥78.3B
Free Cash Flow¥-33401499648
Industry P/E31.4
Technical Analysis
TrendBearish
RSI60.8
Support¥2,248.00
Resistance¥2,511.00
MA 20¥2,367.28
MA 50¥2,424.05
MA 200¥2,670.55
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair Value¥1,830.65
Target Price¥2,606.00
Upside/Downside5.46%
GradeOvervalued
TypeValue
Dividend Yield3.32%
Risk Assessment
Beta0.27
Volatility21.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.